Jessica N. Abraham | Designer. Writer. Publicist.

19+ Years of Expertise in Digital Marketing, Social Branding and Public Relations.

  • Home
  • Contact
  • About
  • Home
  • Contact
  • About

No Widgets found in the Sidebar Alt!

  • Technical advancements in stem cell therapies have reportedly shifted the outlook of regenerative medicine, and some scientists are getting increasingly excited. Cardiologist Dr. Joshua Hare is one of those scientists, and he’s both the co-founder and chief scientific officer of Longeveron Inc. (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions. He’s also credited with helping to pioneer the use of stem cells as medicine for the human heart and regularly explores a future where regenerative medicine can prolong human life.
    Benzinga,  Biotechnology,  Health,  Nature,  Regenerative Medicine

    Should Aging Be Treated As A Disease? And How One Company Might Be Shifting The Paradigm To Reverse It

    June 15, 2022 /

    Originally Published on Benzinga Technical advancements in stem cell therapies have reportedly shifted the outlook of regenerative medicine, and some scientists are getting increasingly excited. Cardiologist Dr. Joshua Hare is one of those scientists, and he’s both the co-founder and chief scientific officer of Longeveron Inc. (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions. He’s also credited with helping to pioneer the use of stem cells as medicine for the human heart and regularly explores a future where regenerative medicine can prolong human life. The global regenerative medicine market  is estimated to reach $6.49 billion in 2027, up 9.3% from $3.05 billion in 2019. …

    read more
    Jessica N. Abraham Comments Off on Should Aging Be Treated As A Disease? And How One Company Might Be Shifting The Paradigm To Reverse It

    You May Also Like

    Carnot® Compressor, National Science Foundation (NSF) and the California Energy Commission (CEC)

    Oil-free Air In, Oil-free Air Out: Solving Problems in Compression and the Environment

    December 14, 2021
    parcelpost parcelpal Last week, ParcelPal Logistics Inc. (OTCQB: PTNYF), a US and Canadian-based organization specializing in last-mile delivery services and logistics-related solutions, announced that it would acquire another well-known and currently unnamed U.S. delivery service, citing a “letter of intent” between both parties after almost 8 months of successful, rapidly-growing co-operations at the company’s west coast facility.

    US and Canadian Delivery Service to Acquire Another U.S. Delivery Services Company, Executes New Canadian Service Agreement in the Same Week

    December 2, 2021
    Crypto, Cryptocurrencies, Trading and leveraging bitcoin to trade derivatives via CFDs.

    How to Leverage More Crypto Using CFDs

    December 6, 2021
  • Cell Transplant, Eye Transplant, Cellular Regeneration, Regeneration Therapy,
    Health,  Benzinga,  Biotechnology,  Business,  Finance,  Regenerative Medicine

    Lineage, Pioneering a New Branch of Medicine — OpRegen Continues to Show Promising Results in Dry AMD with Geographic Atrophy

    October 21, 2021 /

    Previously Published on Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Lineage Cell Therapeutics Inc. (AMEX: LCTX) recently provided an update on its lead program OpRegen®, a cell replacement therapy for dry age-related macular degeneration (AMD) with geographic atrophy (GA).  Lineage is pioneering a new branch of medicine, which is manufacturing differentiated cell types and transplanting those cells into the body, to restore or improve function which has been lost due to injury or disease.  The data from an ongoing Phase 1/2a clinical study continued to demonstrate that a single administration of OpRegen, an investigational cell therapy consisting of…

    read more
    Jessica N. Abraham Comments Off on Lineage, Pioneering a New Branch of Medicine — OpRegen Continues to Show Promising Results in Dry AMD with Geographic Atrophy

    You May Also Like

    Goats, Animal Bedding, anti-pest, anti-mold, anti-bacterial, industrial hemp industry,

    Research Shows that Animals, too, Need a Good Night’s Sleep

    September 14, 2021
    Statera Biopharmaceuticals, Groundbreaking Biomedicine Treatment

    Statera BioPharma: The Ticker Formerly Known as CBLI

    September 7, 2021
    Technical advancements in stem cell therapies have reportedly shifted the outlook of regenerative medicine, and some scientists are getting increasingly excited. Cardiologist Dr. Joshua Hare is one of those scientists, and he’s both the co-founder and chief scientific officer of Longeveron Inc. (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions. He’s also credited with helping to pioneer the use of stem cells as medicine for the human heart and regularly explores a future where regenerative medicine can prolong human life.

    Should Aging Be Treated As A Disease? And How One Company Might Be Shifting The Paradigm To Reverse It

    June 15, 2022
  • Age-Related Macular Degeneration DRY AMD, Lineage Cell Therapeutics
    Business,  Benzinga,  Finance,  Health,  Regenerative Medicine

    Age-Related Macular Degeneration: What is Dry AMD, and How is Lineage Cell Therapeutics Changing the Game?

    August 11, 2021 /

    Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Age-related macular degeneration (AMD) is a disease originating in the retina, which may worsen over time, according to WebMD. It’s said to be the leading cause of severe, permanent vision loss in people older than 60.  When the macula — the small central portion of the retina — wears down, the light-sensing nerve tissue at the back of the eye begins to deteriorate. While it doesn’t always cause complete blindness, severe vision problems such as loss of central vision may occur. As the condition worsens,…

    read more
    Jessica N. Abraham Comments Off on Age-Related Macular Degeneration: What is Dry AMD, and How is Lineage Cell Therapeutics Changing the Game?

    You May Also Like

    Contests,Content Development, Tech News, Technology, Technology News, Content, Customer Experience,Demand,Digital Pivot,Downloads,Exclusivity,Gamification,Giveaways,Incentive-Based Selling,Interaction,Marketing,Mobile Advertising,Mobile App Development,Mobile Marketing,Niche Markets,Personalization,Popularity,Sales,Sampling,Stud,ySurvey,Talent Zoo,Technology,Testing,U,IUser Experience,UX,Compulsive Behavior,Connected Devices,Consumer Interests,Convenience,Couponing,Digital Pivote,Commerce,Exclusive Offers,Locational Shopping,Maryann Moschides,Mobile Advertising,Mobile Incentives,Personalized Experiences,Scanbury Shopper Survey,Shopper Experience,Shopping Habits,Study,Talent Zoo,Behavioral Analysis, Personality Types, Personality Traits,Technology News, DIgital Pivot, Tech, Technology News, Technology,

    Study Shows Mobile Incentives & Convenience Influence Shopping Habits

    January 26, 2016
    IotaComm, IoT, Internet of Things, Smart Buildings, Smart Cities, Finance, Benzinga, Connected, Building Intelligence, Building Analytics,

    This Tool Uses IoT to Turn Old Buildings into Data Powerhouses, Improves Air Quality and Keeps Staff Healthy

    August 27, 2021
    CBD Vape, Mood Management, Canopy Growth, Cannabis, Medical Cannabis, Mental Health, Toxic Free Vaping, Healthy Vaping, Health and Wellness,

    Change Your Mood with a Quick Hit: Canopy Growth Launches whisl, First-Ever CBD Vape

    September 15, 2021
  • Business
  • Technology
  • Career Development
  • Education
  • Entertainment
  • Fashion
  • Relationships
  • Tips
  • Travel
Ashe Theme by WP Royal.